Model-based eligibility for lung cancer screening: Where theory meets practice

Annals of Internal Medicine

Volumn 168, Issue 3, 2018, Pages 223-224

  Green, Angela K ^a   Bach, Peter ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HUMAN; LUNG CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MASS SCREENING; ORGANIZATION AND MANAGEMENT;

COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; ELIGIBILITY DETERMINATION; HUMANS; LUNG NEOPLASMS; MASS SCREENING;

EID: 85042042666     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M17-3316     Document Type: Editorial

References (10)

1. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst. 2003;95:470-8. [PMID: 12644540]
2. Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368:728-36. [PMID: 23425165] doi:10.1056/NEJMoa 1211776
3. Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK. Development and validation of risk models to select ever-smokers for ct lung cancer screening. JAMA. 2016;315:2300-11. [PMID: 27179989] doi:10.1001/jama.2016.6255
4. Bach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med. 2012;157:571-3. [PMID: 22893040]
5. Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, et al. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. PLoS Med. 2017;14: e1002277. [PMID: 28376113] doi:10.1371/journal.pmed.1002277
6. Cheung LC, Katki HA, Chaturvedi AK, Jemal A, Berg CD. Preventing lung cancer mortality by computed tomography screening: the effect of risk-based versus U.S. Preventive Services Task Force eligibility criteria, 2005–2015. Ann Intern Med. 2018;168:229-32. doi:10 .7326/M17-2067
7. Kumar V, Cohen JT, van Klaveren D, Soeteman DI, Wong JB, Neumann PJ, et al. Risk-targeted lung cancer screening. A cost-effectiveness analysis. Ann Intern Med. 2018;168:161-9. doi:10 .7326/M17-1401
8. Jemal A, Fedewa SA. Lung cancer screening with low-dose computed tomography in the United States—2010 to 2015. JAMA Oncol. 2017;3:1278-1281. [PMID: 28152136] doi:10.1001/jamaoncol.2016 .6416
9. U.S. Preventive Services Task Force. Final Recommendation Statement. Lung Cancer: Screening. December 2016. Accessed at www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lung-cancer-screening on 12 December 2017.
10. Centers for Medicare & Medicaid Services. Voting questions. Accessed at www.cms.gov/Regulations-and-Guidance/Guidance/FACA/Downloads/id68b.pdf on 12 December 2017.